Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057495 · ClinicalTrials.gov registry record · NA
The Acute Effect of Mango Intake (Mangifera Indica L.) on Blood Pressure and Blood Glucose
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04057495: Completed NA study, sponsored by University of California, Davis.
NCT04057495 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04057495, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
In the current proposal the investigators seek to evaluate the acute effects of mango intake on blood pressure, blood glucose and insulin in postmenopausal women between 50 and 70 years old.
Primary Outcome
Changes in measures of blood pressure (mmHg) from baseline to two hours following fasting or consumption of white bread or mango.
Interventions
- OTHER further fasting
- OTHER white bread consumption
- OTHER mango consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2020-04-01 |
| Phase | NA |
What the finished NCT04057495 record still lists
NCT04057495 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which further fasting is the first listed.
NCT04057495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04057495 about?
NCT04057495 is a clinical study titled "The Acute Effect of Mango Intake (Mangifera Indica L.) on Blood Pressure and Blood Glucose". In the current proposal the investigators seek to evaluate the acute effects of mango intake on blood pressure, blood glucose and insulin in postmenopausal women between 50 and 70 years old.
What is the current status of trial NCT04057495?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-11-11. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT04057495?
The interventions under investigation include: further fasting (OTHER), white bread consumption (OTHER), mango consumption (OTHER).
Who is sponsoring clinical trial NCT04057495?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04057495's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI